Comparative study of peripheral neurotoxicity after injection of two different paclitaxel formulations in rats

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 4, 2010, Pages 205-209

  Nakamura, Iwao ^a   Ichimura, Eiji ^a   Kobayashi, Hiroaki ^b   Mashiba, Hiroko ^a   Nagai, Daichi ^a   Ebara, Keiko ^a   Hayashi, Hitomi ^a   Okamoto, Kazuya ^a   Wake, Norio ^b   Nishikawa, Kiyohiro ^a  

^a NIPPON KAYAKU CO LTD   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Antitumor agent; CAS 33069 62 4; Histopathological study; Nerve conduction study; Paclitaxel, injection, rat; Sensory neuropathy

Indexed keywords

PACLITAXEL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG FORMULATION; DRUG SAFETY; ELECTROPHYSIOLOGY; FEMALE; HISTOPATHOLOGY; MYELINATED NERVE; NERVE CONDUCTION; NERVE POTENTIAL; NEUROTOXICITY; NONHUMAN; RAT; SCIATIC NERVE; SENSORY NERVE; SURAL NERVE;

EID: 77951708884     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296274     Document Type: Article

References (20)

1. Carney DN. Chemotherapy in the management of patients with inoperable non-small cell lung cancer. Semin Oncol. 1996;23:71-75 (Pubitemid 27068992)
2. Crown J and O'Leary M. The taxanes: an update. Lancet. 2000;355:1176-1178.
3. Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC. Neurotoxicity of Taxol. J Natl Cancer Inst Monogr. 1993;107-115.
4. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med. 1995;332: 1004-1014.
5. Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, et al. Taxol produces a predominantly sensory neuropathy. Neurology. 1989;39:368-373 (Pubitemid 19094727)
6. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37:1590-1598 (Pubitemid 32778603)
7. van Tellingen O, Huizing MT, Panday VR, Schellens JH, Nooijen WJ, Beijnen JH, et al. Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients. Br J Cancer. 1999;81:330-335.
8. Sagara Y, Rai Y, Matsuyama Y, Baba S, Tamada S, Ando M. Comparison of the pharmacokinetics and safety of a paclitaxel injection NK and taxol injection in breast cancer patients. Gan To Kagaku Ryoho. 2009;36:247-250.
9. Goda R, Yamaguchi T, Yamashita T, Yazawa Y, Kawashiro T, Arai S, et al. Plasma concentration in dogs, compatibility and drip rate of Paclitaxel Inj. 30 mg/5mL [NK]. Jap J Med Pharmaceut Sci. 2006;56l:563-570.
10. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol. 1994;35:304-311 (Pubitemid 24089653)
11. Sahenk Z, Barohn R, New P, Mendell JR. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol. 1994;51:726-729.
12. Apfel SC, Lipton RB, Arezzo JC, Kessler JA. Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol. 1991;29:87-90.
13. Cavaletti G, Cavalletti E, Montaguti P, Oggioni N, De Negri O, Tredici G. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology. 1997:18;137-145.
14. Cavaletti G, Tredici G, Braga M, Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol. 1995;133: 64-72.
15. Cliffer KD, Siuciak JA, Carson SR, Radley HE, Park JS, Lewis DR, et al. Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol. 1998;43:46-55.
16. Jamieson SM, Liu JJ, Connor B, Dragunow M, McKeage MJ. Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel. Neurotoxicology. 2007;28:1092-1098 (Pubitemid 350026583)
17. Persohn E, Canta A, Schoepfer S, Traebert M, Mueller L, Gilardini A, et al. Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. Eur J Cancer. 2005;41:1460-1466 (Pubitemid 40826471)
18. Peters CM, Jimenez-Andrade JM, Jonas BM, Sevcik MA, Koewler NJ, Ghilardi JR, et al. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol. 2007;203:42-54.
19. Mimura Y, Kato H, Eguchi K, Ogawa T. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study. Neurotoxicology. 2000;21:513-520.
20. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50:219-244.